According to Reuters, Anvisa's experts have recommended that the vaccine. if approved, "only be used on healthy adults."

Earlier it was reported that Anvisa would again consider the issue of import and emergency use of the Sputnik V vaccine on June 4, after refusing permission twice this year, citing lack of information.